Therapeutic effect of Active Hexose-Correlated Compound (AHCC) combined with CpG-ODN (oligodeoxynucleotide) in B16 melanoma murine model. Issue 2 (December 2015)

• Record Type: Journal Article
• Authors: Ignacio, Rosa Mistica; Kim, Cheol-Su; Kim, Young-Do; Lee, Hak-Min; Qi, Xu-Feng; Kim, Soo-Ki
• Is Part Of: Cytokine. Volume 76:Issue 2(2015)
• Page Start: 131
• Page End: 137
• Publication Date: 2015-12
• Subjects: Cytokines -- Periodicals; 571.844
• DOI: 10.1016/j.cyto.2015.06.002
• Languages: English
• ISSNs: 1043-4666

Abstract

<abstract xml:lang="en" abstract-type="author-highlights" id="ab005"> <title id="st005">Highlights</title> <sec> <p id="sp0005"> <list id="l0005"> <list-item id="o0005"> <label></label> <p id="p0005">Combined therapy of AHCC plus TLR9 agonist (CpG-ODN) is effective in melanoma.</p> </list-item> <list-item id="o0010"> <label></label> <p id="p0010">Combined AHCC and KSK-CpG ODN improves redox balance in murine melanoma.</p> </list-item> <list-item id="o0015"> <label></label> <p id="p0015">Combined AHCC and KSK-CpG ODN improves cytokine balance in murine melanoma.</p> </list-item> </list> </p> </sec> </abstract>